End-to-End Clinical Trial Data Management for a New Diabetes Drug (GlucoHealX)
End-to-End Clinical Trial Data Management for a New Diabetes Drug (GlucoHealX)
1. Problem Definition (Storytelling Approach)
Background & Business Case
PharmaGenix, a leading global pharmaceutical company, is conducting a Phase III, multicenter, double-blind, placebo-controlled clinical trial to evaluate the safety and efficacy of GlucoHealX, a novel drug for Type 2 Diabetes Mellitus (T2DM). The study involves 3,000 patients across 15 countries, with a study duration of 18 months.
Challenges in the Clinical Trial Data Management Process:
- High volume of data from multiple sites
- Missing values, protocol deviations, and duplicate entries in the dataset
- Data standardization to comply with CDISC SDTM & ADaM models
- Adverse event tracking and serious adverse event (SAE) reporting
- Regulatory submission (FDA, EMA) compliance
- Integration of SAS-based automation to ensure data integrity
2. Scope of Work
The project covers the entire lifecycle of clinical data management, including:
A. Data Management
- CRF Design – Case Report Forms for demographics, vital signs, lab results, adverse events, etc.
- Database Setup – Implementing an electronic data capture (EDC) system.
- Data Validation & Cleaning – Identifying outliers, handling missing values, standardizing formats.
B. Data Processing in SAS
- Creating SAS datasets for key clinical domains (demographics, vitals, lab tests, etc.).
- Data transformations – Standardizing variables, deriving new variables, merging datasets.
- Serious Adverse Events (SAE) reporting – Automating identification of severe patient conditions.
C. Statistical Analysis & Regulatory Compliance
- Survival analysis (Kaplan-Meier method) – Assessing time-to-event data.
- ANOVA & Logistic Regression – Identifying efficacy differences across treatment groups.
- Compliance with FDA/CDISC SDTM standards – Creating submission-ready datasets.
3. Project Timeline (Gantt Chart)
| Task | Start Date | End Date | Duration |
|---|---|---|---|
| CRF Design | Day 1 | Day 10 | 10 days |
| Dataset Creation | Day 11 | Day 25 | 15 days |
| Data Validation | Day 26 | Day 40 | 15 days |
| Data Analysis & Reporting | Day 41 | Day 60 | 20 days |
| Regulatory Submission | Day 61 | Day 75 | 15 days |
4. Dataset Creation (SAS Code with Data)
A. Demographics Dataset
data work.demographics;
input PatientID $ Age Sex $ Race $ Country $ BMI SmokingStatus $;
datalines;
P001 52 M Asian USA 27.5 Yes
P002 64 F White Canada 30.2 No
P003 45 M Black UK 29.8 Yes
P004 59 F Hispanic India 28.1 No
P005 63 M Asian Germany 31.4 Yes
;
run;
B. Vital Signs Dataset
data work.vitals;
input PatientID $ VisitDate mmddyy10. Systolic Diastolic HeartRate Weight;
format VisitDate mmddyy10.;
datalines;
P001 01/05/2024 140 90 78 75.2
P002 01/07/2024 130 85 72 68.5
P003 01/10/2024 150 95 80 82.3
;
run;
C. Lab Test Results Dataset
data work.lab_results;
input PatientID $ VisitDate mmddyy10. HbA1c Glucose Creatinine;
format VisitDate mmddyy10.;
datalines;
P001 01/05/2024 6.8 145 1.1
P002 01/07/2024 7.2 155 1.3
P003 01/10/2024 6.5 138 1.0
;
run;
D. Adverse Events Dataset
data work.adverse_events;
input PatientID $ AE_Type $ AE_Severity $ AE_Resolution $ Serious_AE $;
datalines;
P001 Hypertension Mild Resolved No
P002 Hypoglycemia Severe Ongoing Yes
P003 Dizziness Moderate Resolved No
;
run;
5. Base SAS & Advanced SAS Implementation
A. Data Cleaning (Handling Missing Values & Outliers)
data work.cleaned_lab;
set work.lab_results;
if missing(HbA1c) then HbA1c = 7.0; /* Impute missing HbA1c values */
if Glucose > 300 then delete; /* Remove extreme glucose values */
run;
B. Serious Adverse Event (SAE) Detection
data work.serious_adverse_events;
set work.adverse_events;
if Serious_AE = "Yes";
run;
C. Treatment Efficacy Analysis (ANOVA)
proc glm data=work.lab_results;
class PatientID;
model HbA1c = Glucose Creatinine;
means HbA1c / hovtest welch;
run;
D. Survival Analysis (Kaplan-Meier)
proc lifetest data=work.survival method=km plots=survival;
time TimeToEvent*Censor(1);
strata TreatmentGroup;
run;
6. Compliance & Regulatory Submission
- Convert datasets to CDISC SDTM format
data work.sdtm_demographics;
set work.demographics;
rename PatientID = USUBJID
Age = AGE
Sex = SEX
Race = RACE
BMI = BMI;
run;
- Generate FDA-compliant reports using PROC REPORT
proc report data=work.sdtm_demographics nowd;
column USUBJID AGE SEX RACE BMI;
run;
7. Delivery Procedure
A. Deliverables
- Final SAS datasets (SDTM format, cleaned and validated).
- Annotated CRFs (documenting how data elements are captured).
- Statistical Analysis Reports (tables, listings, and figures).
- FDA/EMA Submission Package (submission-ready datasets & reports).
- SAS Codes & Macros Documentation.
8. Summary
- This is a full-scale, industry-level clinical data management project with datasets, cleaning, transformations, analysis, and reporting.
- It follows CDISC, SDTM, and FDA submission standards, making it realistic for Clinical Research Organizations (CROs).
- The project demonstrates expertise in Base SAS & Advanced SAS for handling real-world clinical trial data.
Would you like any additional modifications, such as adding SAS Macros, Data Validation Reports, or FDA Submission Formats?
9. SAS Macros for Automation
A. Macro to Identify Missing Values in Any Dataset
B. Macro to Generate CDISC SDTM-Compliant Datasets
C. Macro for FDA-Compliant Adverse Event Report
10. Data Validation Reports
A. Detecting Data Issues (Duplicate Records, Outliers, Missing Values)
B. Generating Data Quality Summary Report
11. FDA Submission Format
A. Create SDTM-Compliant Dataset
B. Generate FDA-Compliant Transport File (XPT)
12. Final Deliverables
-
Fully automated SAS code for data validation, transformation, and reporting.
-
CDISC SDTM datasets ready for FDA submission.
-
FDA-compliant reports and transport files (XPT format).
-
Data validation reports for quality assurance.
-
SAS macros to automate repetitive tasks in Clinical Data Management.

Comments
Post a Comment